InMode (INMD) Revenue Growth (1y) (2019 - 2026)
InMode (INMD) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 6.08% |
| 10 | InMode | 978,594.46 | -479.15 Mn | 61.55 Mn | 5.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.32% |
| Dec 31, 2025 | 6.13% |
| Sep 30, 2025 | -28.46% |
| Jun 30, 2025 | 10.59% |
| Mar 31, 2025 | -3.00% |
| Dec 31, 2024 | -22.82% |
| Sep 30, 2024 | 5.78% |
| Jun 30, 2024 | -36.47% |
| Mar 31, 2024 | -24.31% |
| Dec 31, 2023 | -5.08% |
| Sep 30, 2023 | 1.55% |
| Jun 30, 2023 | 19.85% |
| Mar 31, 2023 | 23.46% |
| Dec 31, 2022 | 20.83% |
| Sep 30, 2022 | 28.73% |
| Jun 30, 2022 | 30.03% |
| Mar 31, 2022 | 31.13% |
| Dec 31, 2021 | 47.02% |
| Sep 30, 2021 | 57.71% |
| Jun 30, 2021 | 183.85% |